LOAN AGREEMENTLoan Agreement • March 5th, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 5th, 2018 Company Industry JurisdictionThis Loan Agreement (this “Loan Agreement”), dated as of March 1, 2018, is entered into between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Borrower”), and LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at Unit 110-111, Bio-Informatics Centre, No. 2 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong (“Lender”).
SECURITY AGREEMENTSecurity Agreement • March 5th, 2018 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 5th, 2018 Company Industry JurisdictionThis Security Agreement, dated as of March 1, 2018 (as amended, supplemented or otherwise modified from time to time in accordance with the provisions hereof, this “Agreement”), made by and among Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (the “Grantor”), in favor of LPH Investments Ltd., a Cayman Islands company organized and existing under the laws of Cayman Islands with its principal offices at Unit 110-111, Bio-Informatics Centre, No. 2 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong (the “Secured Party”).